-
Share
13,539 Posts.
2708
10/12/08
06:54
Share
Excellent point SSV - you are on a roll.
It will, as you say, provide all the clinical data for the studies required for a resubmission to FDA.
Not that the company will 'need' those markets if China fires up.
SSV, you were right in your comments last night that China is unfolding just as we have been anticipationg for around 9 months now.
Definitely a matter of WHEN now, not IF!
-
